Concepedia

Misako Nagasaka

MN

Statistics

Publications

89

Citations

4.5K

H-Index

33

Active since

2016

Affiliations

The Barbara Ann Karmanos Cancer Institute(Current)

University of California, Irvine

St. Marianna University School of Medicine

Wayne State University

Memorial Sloan Kettering Cancer Center

Misako Nagasaka is an author at The Barbara Ann Karmanos Cancer Institute specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2016–2025

89

Publications

89

Trastuzumab Deruxtecan in <i>HER2</i> -Mutant Non–Small-Cell Lung Cancer

Bob T. Li, Egbert F. Smit, Yasushi Goto et al. · New England Journal of Medicine · 2021 · 980 citations · Full text

, , +16

Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial

Jamie E. Chaft, Filiz Öezkan, Mark G. Kris et al. · Nature Medicine · 2022 · 237 citations · Full text

, , +17

Repotrectinib in <i>ROS1</i> Fusion–Positive Non–Small-Cell Lung Cancer

Alexander Drilon, D. Ross Camidge, Sang‐We Kim et al. · New England Journal of Medicine · 2024 · 210 citations · Full text

, , +16

Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors

Jessica Lee, Smruthy Sivakumar, Alexa B. Schrock et al. · npj Precision Oncology · 2022 · 167 citations · Full text

, , +17

Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial

Egbert F. Smit, Enriqueta Felip, Dipesh Uprety et al. · The Lancet Oncology · 2024 · 156 citations · Full text

, , +16

1–5 of 89